HERON ELAINE J 4
4 · PALVELLA THERAPEUTICS, INC. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Palvella (PVLA) Director Heron Elaine J Buys 2,400 Shares
What Happened Heron Elaine J, a director of Palvella Therapeutics, purchased 2,400 shares of Palvella common stock at $125.00 per share on February 27, 2026, for a total of $300,000. This was a purchase (insider buy), reported on a Form 4 filed March 2, 2026.
Key Details
- Transaction date and price: 2026-02-27 — 2,400 shares at $125.00 per share.
- Total value: $300,000.
- Transaction type: P (purchase) — shares acquired in an underwritten offering (see footnote).
- Footnote: F1 — represents shares purchased in the company’s underwritten offering, which closed on February 27, 2026.
- Filing: Form 4 filed 2026-03-02; filing appears timely (within the required two-business-day window).
- Shares owned after transaction: Not specified in the provided filing.
Context This purchase was part of an underwritten offering (an allocation at the offering price), not a spontaneous open-market buy. Insider purchases can signal confidence but do not by themselves prove future performance; allocations in offerings can reflect negotiated participation. No options exercises, gifts, or tax-withholding events are reported for this transaction.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-02-27$125.00/sh+2,400$300,000→ 47,812 total
- 5,879(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.